U.S. Sens. Christopher Murphy (D-CT) and Shelley Moore Capito (R-WV) recently sent a letter to Sens. Lamar Alexander (R-TN) and Patty Murray (D-WA), chairman and ranking member of the Senate Health, Education, Labor and Pensions (HELP) Committee respectively, to review patients’ perspectives on high out-of-pocket costs and their ability to access health care.

For those who are no fans of the Affordable Care Act (ACA)  Dr. Kris Held, a Texas ophthalmologist and health care policy analyst, recently said that Obamacare is nothing compared to the Medicare Access and CHIP Reauthorization Act (MACRA) law.

U.S. Sen. Richard Blumenthal (D-CT) distilled the main points of his letter to the Department of Justice (DOJ) addressing concerns about the proposed Aetna-Humana and Anthem-Cigna mergers at a press conference today.

Arizona residents may soon be paying a whole lot more for health care under the Affordable Care Act. 

Insurance companies and industry analysts are still skeptical about the future of the Affordable Care Act (ACA). 

Deductibles and out-of-pocket costs for health insurance plans have soared since 2010, with deductibles alone rising 67 percent — about seven times as fast as wages and inflation, a recent study by ValuePenguin found.

Highmark has announced that, starting April 1, it will pay doctors 4.5 percent less for treating patients who have health insurance through the federal Affordable Care Act (ACA) marketplace.

The Affordable Care Act (ACA) is under more fire from Republican critics, who claim the law was broken when ACA payments were restructured to pay insurance providers before the U.S. Treasury had received its payments.

People purchasing health insurance through the ACA have run into another insurance roadblock, this time because out-of-network doctors providing services for in-network hospitals may bill separately from the hospital, creating expensive, surprise expenses for the patient.

When the Affordable Care Act (ACA) was first passed, both supporters and opponents expected road blocks and possible setbacks as health care became more accessible and government supported.

Tax season is well underway and many filers are finding themselves surprised by the impact subsidies received under the Affordable Care Act (ACA) is having on what they get back or what they have to pay.

After New York’s attorney general requested information from 16 health insurance companies over allegations they were restricting coverage of drugs that can cure hepatitis C, Aetna said it will expand coverage for some of the medications and will continue to do so as new research findings become available. 

Dr. Anthony LoSasso, professor of health policy and administration at the University of Illinois at Chicago, has been focusing on health insurance issues involving ACA expansion, insurance programs and benefit design.

Marah Short, associate director of the Center for Health and Biosciences at Rice University’s Baker Institute for Public Policy, started out doing research for cancer care policies, but since the ACA, her focus has predominately been on studying the effects of the ACA and how health care can be managed more effectively.

Emergency room drug shortages have been a continuous issue that only seems to be getting worse, Reuters recently reported, claiming a 400 percent rise since 2008.

An audit of the Colorado Connect for Health exchange released by the U.S. Department of Health and Human Services this month said the inspector general found security issues weren't properly addressed in some cases and possibly exposed the personal information of residents participating in the exchange.

A recent report by Stanford and Harvard University researchers details how the mandate to cover dependents until 26 years of age is costing American families more than what was disclosed.

Democratic candidate Hillary Clinton announced in late September that she would demand a stop to excessive profiteering and marketing costs by encouraging innovation and new treatments from drug companies — including a stop to direct-to-consumer drug company advertising subsidies — and reinvesting funds in research.

The Congressional Budget Office recently lowered the health care enrollment projections for 2016 by almost 40 percent. James Capretta, senior fellow at the American Enterprise Institute, said this reduction can be explained by previous projections that were unrealistically high.

Richard Zaldivar, founder and executive vice president of The Wall Las Memorias project, a Latino HIV/AIDS advocacy group, has been vocal in his concerns about price caps on medications and is worried they could limit innovation and future investment.